[D1-sobrerol in the treatment of acute and chronic bronchopulmonary phlogoses].
D000433:1-Propanol / Q000627:therapeutic use; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000438:Alcohols / Q000627:therapeutic use*; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000008:administration & dosage / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006801:Humans; D008875:Middle Aged; D011656:Pulmonary Emphysema / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D000438:Alcohols; D003510:Cyclohexanes; D003511:Cyclohexanols; D000433:1-Propanol
Il dl sobrerolo nel trattamento delle flogosi broncopolmonari acute e croniche.